Page last updated: 2024-09-03
y 26763 and Asthma
y 26763 has been researched along with Asthma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Furlong, J; Graham, BS; Hartert, TV; Hashimoto, K; Jarzecka, K; Mitchell, DB; Peebles, RS; Sheller, JR | 1 |
Other Studies
1 other study(ies) available for y 26763 and Asthma
| Article | Year |
|---|---|
Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor.
Topics: Airway Resistance; Animals; Antihypertensive Agents; Asthma; Benzopyrans; Bronchial Hyperreactivity; Dose-Response Relationship, Drug; Female; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Syncytial Virus Infections | 2002 |